In contrast, the studies that included only subjects with type 1 diabetes receiving insulin therapy or individuals with both type 1 and type 2 diabetes showed an increased time in hyperglycemia and glucose variability during RF [15,16,17]. The gene discussed is INS; the disease is Hyperglycemia.